REPORTS

Let’s Pullulate and Expand Your Business

Oncology Drug Delivery Market - Global Professional Analysis and Forecast to 2026

Oct 13, 2019  |  141 PAGES  |  REPORT CODE: CMM207499
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Oncology Drug Delivery market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.3% during the forecast period.

This report presents the market size and development trends by detailing the Oncology Drug Delivery market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Oncology Drug Delivery market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Oncology Drug Delivery industry and will help you to build a panoramic view of the industrial development.

Oncology Drug Delivery Market, By Type:

  • Type 1

  • Type 2

  • Type 3

Oncology Drug Delivery Market, By Application:

  • End-Users 1

  • End-Users 2

  • End-Users 3

Some of the leading players are as follows:

  • NEONC Technologies Inc. (NTI)

  • Juno Therapeutics, Inc.

  • Becton, Dickinson and Company (BD)

  • West Pharmaceuticals

  • Evotec AG

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Oncology Drug Delivery Market: Technology Type Analysis

  • 4.1 Oncology Drug Delivery Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Oncology Drug Delivery Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 Oncology Drug Delivery Market: Product Analysis

  • 5.1 Oncology Drug Delivery Product Market Share Analysis, 2018 & 2026

  • 5.2 Oncology Drug Delivery Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Oncology Drug Delivery Market: Application Analysis

  • 6.1 Oncology Drug Delivery Application Market Share Analysis, 2018 & 2026

  • 6.2 Oncology Drug Delivery Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 Oncology Drug Delivery Market: Regional Analysis

  • 7.1 Oncology Drug Delivery Regional Market Share Analysis, 2018 & 2026

  • 7.2 Oncology Drug Delivery Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 NEONC Technologies Inc. (NTI)

    • 9.1.1 NEONC Technologies Inc. (NTI) Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Juno Therapeutics, Inc.

    • 9.2.1 Juno Therapeutics, Inc. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Becton, Dickinson and Company (BD)

    • 9.3.1 Becton, Dickinson and Company (BD) Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 West Pharmaceuticals

    • 9.4.1 West Pharmaceuticals Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Evotec AG

    • 9.5.1 Evotec AG Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

 

The List of Tables and Figures (Totals 64 Figures and 162 Tables)

  • Figure Type 1 Oncology Drug Delivery market, 2015 - 2026 (USD Million)

  • Figure Type 2 Oncology Drug Delivery market, 2015 - 2026 (USD Million)

  • Figure Type 3 Oncology Drug Delivery market, 2015 - 2026 (USD Million)

  • Figure End-Users 1 market, 2015 - 2026 (USD Million)

  • Figure End-Users 2 market, 2015 - 2026 (USD Million)

  • Figure End-Users 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Oncology Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table North America Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table North America Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table North America Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Canada Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Canada Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Europe Oncology Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table Europe Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Europe Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Europe Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Germany Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Germany Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table France Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table France Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Italy Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Italy Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Spain Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Spain Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Oncology Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table China Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table China Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Japan Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Japan Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table India Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table India Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Oncology Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table MEA Oncology Drug Delivery market, by country, 2015 - 2026 (USD Million)

  • Table MEA Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table MEA Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table MEA Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Oncology Drug Delivery market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Oncology Drug Delivery market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Oncology Drug Delivery market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table NEONC Technologies Inc. (NTI) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Juno Therapeutics, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Becton, Dickinson and Company (BD) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table West Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Evotec AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top